{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:14:28Z","timestamp":1770977668997,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jad.2019.10.012","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T11:13:53Z","timestamp":1570792433000},"page":"259-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-1346","authenticated-orcid":false,"given":"Yuanhan","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.10.012_bib0001","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1093\/bja\/69.supplement_1.2S","article-title":"Physiology of nausea and vomiting","volume":"69","author":"Andrews","year":"1992","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jad.2019.10.012_bib0002","first-page":"1","article-title":"Comparison of common side effects. from mood stabilizers and antipsychotics between pediatric and adult patients with bipolar disorder: a systematic review of randomized, double-blind, placebo-controlled trials","author":"Bai","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2019.10.012_bib0003","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/pgs.14.65","article-title":"Pharmacogenetics of. antiepileptic drug-induced hypersensitivity","volume":"15","author":"Bloch","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2019.10.012_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2019.10.012_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/0269881112473789","article-title":"Weight change by. baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database.","volume":"27","author":"Bushe","year":"2013","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.jad.2019.10.012_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jad.2007.07.023","article-title":"Cross-national difference in the prevalence of depression caused by the diagnostic threshold","volume":"106","author":"Chang","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0007","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1034\/j.1399-5618.2000.020407.x","article-title":"Response to placebo among bipolar I disorder patients experiencing their first manic episode","volume":"2","author":"Chengappa","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2842.2009.02037.x","article-title":"Salivary flow rate and clinical. characteristics of patients with xerostomia according to its aetiology","volume":"37","author":"Cho","year":"2010","journal-title":"J. Oral Rehabil."},{"key":"10.1016\/j.jad.2019.10.012_bib0009","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2017.07.037","article-title":"Oral health impacts of medications used to treat mental illness","volume":"223","author":"Cockburn","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2019.10.012_bib0011","article-title":"Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.jad.2019.10.012_bib0012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1192\/pb.bp.109.026435","article-title":"Race and prescribing","volume":"34","author":"Connolly","year":"2010","journal-title":"Psychiatrist"},{"key":"10.1016\/j.jad.2019.10.012_bib0013","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/NDT.S83989","article-title":"Rare and very rare adverse effects of clozapine","volume":"11","author":"De Fazio","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.10.012_bib0014","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40263-016-0352-5","article-title":"Antipsychotic. drug-induced somnolence: incidence, mechanisms, and management","volume":"30","author":"Fang","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2019.10.012_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/14737175.2016.1276284","article-title":"Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?","volume":"17","author":"Fang","year":"2017","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jad.2019.10.012_bib0016","first-page":"31790","article-title":"International conference on harmonisation; guidance on ethnic factors in. the acceptability of foreign clinical data; availability\u2013FDA. notice.","volume":"63","year":"1998","journal-title":"Fed. Regist."},{"key":"10.1016\/j.jad.2019.10.012_bib0017","first-page":"180","article-title":"The International college of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction. of CYP2D6 phenotype from genotype across world populations","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.jad.2019.10.012_bib0019","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2105\/AJPH.87.11.1773","article-title":"Under the shadow of Tuskegee: African Americans and health Care","volume":"87","author":"Gamble","year":"1997","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jad.2019.10.012_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/JCP.0000000000000596","article-title":"Subjective versus objective weight. Gain during acute treatment with second-generation antipsychotics in schizophrenia and bipolar disorder","volume":"36","author":"Gao","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0021","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4088\/JCP.v69n0217","article-title":"A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence","volume":"69","author":"Gao","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review","volume":"28","author":"Gao","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JCP.0000000000001031","article-title":"Longitudinally measured changes in somnolence severity with a visual analog scale in a randomized lithium versus quetiapine-ir study in bipolar disorder","volume":"39","author":"Gao","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.jad.2019.10.012_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2017.1384850","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states in bipolar disorder","volume":"19","author":"Grunze","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/2168479018791539","article-title":"Regulatory trends in drug development in Asia pacific","volume":"53","author":"Han","year":"2019","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.jad.2019.10.012_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4306\/pi.2017.14.1.63","article-title":"Efficacy and safety of bitopertin in patients with schizophrenia and predominant negative symptoms: subgroup analysis of japanese patients from the global randomized phase 2 trial","volume":"14","author":"Hirayasu","year":"2017","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2019.10.012_bib0028","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0029","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tripleo.2005.12.001","article-title":"Impact of dry mouth and hyposalivation on oral health-related quality of life of elderly japanese","volume":"103","author":"Ikebe","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.jad.2019.10.012_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134208","article-title":"Identification of adverse drug events from free text electronic patient records and information in a large mental health case register","volume":"10","author":"Iqbal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2019.10.012_bib0031","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/pcn.12060","article-title":"Guideline for treatment of bipolar disorder by the Japanese society of mood disorders, 2012","volume":"67","author":"Kanba","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2019.10.012_bib0032","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/15622975.2012.669047","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the amaze study)","volume":"15","author":"Kanba","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0033","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jad.2011.10.045","article-title":"Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study","volume":"136","author":"Katagiri","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0034","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-244X-13-138","article-title":"Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study","volume":"13","author":"Katagiri","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0036","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0006-3223(99)00311-X","article-title":"Placebo effect in randomized, controlled studies of acute bipolar mania and depression","volume":"47","author":"Keck","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0037","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0038","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0039","first-page":"2825","article-title":"A combined HRV-FMRI approach to assess cortical control of cardiovagal modulation by motion sickness","volume":"2011","author":"Kim","year":"2011","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.jad.2019.10.012_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00051427","article-title":"Neurasthenia and depression: a study of somatization and culture in China","volume":"6","author":"Kleinman","year":"1982","journal-title":"Cult. Med. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0041","first-page":"A09","article-title":"Adherence to oral hypoglycemic agents in Hawaii","volume":"2","author":"Lee","year":"2005","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.jad.2019.10.012_bib0042","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00213-016-4215-z","article-title":"Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Li","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jad.2019.10.012_bib0043","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2019.10.012_bib0044","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2017.09.003","article-title":"Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: a systematic review and meta-analysis","volume":"195","author":"Liu","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jad.2019.10.012_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072143","article-title":"A history of the pharmacological treatment of bipolar disorder","volume":"19","author":"Lopez-Munoz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2019.10.012_bib0046","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0047","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00213-018-4977-6","article-title":"Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression","volume":"235","author":"Murasaki","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jad.2019.10.012_bib0048","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/cercor\/bhs073","article-title":"The brain circuitry underlying the temporal evolution of nausea in humans","volume":"23","author":"Napadow","year":"2013","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jad.2019.10.012_bib0049","series-title":"Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","article-title":"Bipolar disorder: the NICE","year":"2018"},{"key":"10.1016\/j.jad.2019.10.012_bib0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00002018-200831070-00005","article-title":"Ethnic differences in. the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis","volume":"31","author":"Ormerod","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.jad.2019.10.012_bib0051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pain.2010.03.011","article-title":"A prefrontal non-opioid mechanism in placebo analgesia","volume":"150","author":"Petrovic","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.jad.2019.10.012_bib0052","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.179.1.4","article-title":"Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem","volume":"179","author":"Poyurovsky","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cpt.61","article-title":"Racial\/ethnic differences in drug disposition and response: review of recently approved drugs","volume":"97","author":"Ramamoorthy","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2019.10.012_bib0054","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0021-843X.117.2.300","article-title":"The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America?","volume":"117","author":"Ryder","year":"2008","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jad.2019.10.012_bib0055","article-title":"The prevalence of orthostatic hypotension: a systematic review and meta-analysis","author":"Saedon","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jad.2019.10.012_bib0056","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1185\/030079903125002973","article-title":"Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials","volume":"20","author":"Sakai","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2019.10.012_bib0057","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008571-200204000-00008","article-title":"Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study","volume":"12","author":"Schillevoort","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jad.2019.10.012_bib0058","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.06.028","article-title":"Individual differences in reward responding explain placebo-induced expectations and effects","volume":"55","author":"Scott","year":"2007","journal-title":"Neuron"},{"issue":"Suppl (1)","key":"10.1016\/j.jad.2019.10.012_bib0059","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S000711450000088X","article-title":"Obesity, insulin resistance and diabetes\u2013a worldwide epidemic","volume":"83","author":"Seidell","year":"2000","journal-title":"Br. J. Nutr"},{"key":"10.1016\/j.jad.2019.10.012_bib0060","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11938-016-0107-x","article-title":"Central aspects of nausea and vomiting in gi disorders","volume":"14","author":"Singh","year":"2016","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"10.1016\/j.jad.2019.10.012_bib0061","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1756283X15618131","article-title":"Nausea: a review of pathophysiology and therapeutics","volume":"9","author":"Singh","year":"2016","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.jad.2019.10.012_bib0062","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0063","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0064","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4088\/JCP.v68n0807","article-title":"A systematic review of placebo response in studies of bipolar mania","volume":"68","author":"Sysko","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13557850701234955","article-title":"Antihypertensive adherence and drug class among Asian Pacific Americans","volume":"12","author":"Taira","year":"2007","journal-title":"Ethn. Health"},{"key":"10.1016\/j.jad.2019.10.012_bib0066","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7525-4-86","article-title":"The impact of. xerostomia on oral-health-related quality of life among younger adults","volume":"4","author":"Thomson","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jad.2019.10.012_bib0067","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Olanzipine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0068","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH study group.","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0069","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1017\/S146114571100040X","article-title":"Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study","volume":"14","author":"Vieta","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0070","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2147\/NDT.S98927","article-title":"Efficacy and safety of olanzapine for treatment of patients with bipolar depression: chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study","volume":"12","author":"Wang","year":"2016","journal-title":"Neuropsychiatr Dis. Treat."},{"key":"10.1016\/j.jad.2019.10.012_bib0071","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bdi.12646","article-title":"Assessment and management of bipolar disorder: principal summary of updated Chinese guidelines","volume":"20","author":"Wang","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0072","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-244X-14-167","article-title":"Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2019.10.012_bib0073","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/fampra\/16.5.528","article-title":"Comparison of symptoms in Japanese and American depressed primary care patients","volume":"16","author":"Waza","year":"1999","journal-title":"Fam. Pract."},{"key":"10.1016\/j.jad.2019.10.012_bib0074","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881115586938","article-title":"Efficacy of drug treatment for acute mania differs across geographic regions: an individual patient data meta-analysis of placebo-controlled studies","volume":"29","author":"Welten","year":"2015","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.jad.2019.10.012_bib0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.9758\/cpn.2018.16.4.434","article-title":"Korean medication algorithm project for bipolar disorder 2018 (KMAP-BP 2018): fourth revision","volume":"16","author":"Woo","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2019.10.012_bib0076","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2019.10.012_bib0077","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1037\/0022-006X.68.6.993","article-title":"A cross-cultural comparison of depressive. symptom manifestation: China and the United States","volume":"68","author":"Yen","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2019.10.012_bib0078","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/S1461145710001641","article-title":"Factors modifying drug and placebo responses in randomized trials for bipolar mania","volume":"14","author":"Yildiz","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.10.012_bib0079","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jemermed.2017.11.031","article-title":"Evidence-Based review of pharmacotherapy for acute agitation. Part 2: safety","volume":"54","author":"Zun","year":"2018","journal-title":"J. Emerg. Med."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719320488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719320488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:31:18Z","timestamp":1759023078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719320488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":79,"alternative-id":["S0165032719320488"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.10.012","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}